RYMPX | SGGDX | RYMPX / SGGDX | |
Total Expense Ratio | 1.55 | 1.16 | 134% |
Annual Report Gross Expense Ratio | 1.58 | 1.16 | 136% |
Fund Existence | 22 years | 32 years | - |
Gain YTD | 52.834 | 53.004 | 100% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 3.8B | 3% |
Annual Yield % from dividends | 0.00 | 3.67 | - |
Returns for 1 year | 55.44 | 62.31 | 89% |
Returns for 3 years | 62.38 | 86.63 | 72% |
Returns for 5 years | 54.53 | 83.01 | 66% |
Returns for 10 years | 140.37 | 195.67 | 72% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 118.30 | -0.61 | -0.51% |
Franklin Biotechnology Discovery A | |||
LMPPX | 35.78 | -0.37 | -1.02% |
ClearBridge Appreciation R | |||
JDPRX | 15.29 | -0.20 | -1.29% |
Janus Henderson Mid Cap Value R | |||
CAREX | 15.98 | -0.22 | -1.36% |
Domini Sustainable Solutions Inv | |||
WAIGX | 24.05 | -0.38 | -1.56% |
Wasatch International Growth Investor |